Details of the Drug

General Information of Drug (ID: DMKYJJC)

Drug Name
Tigatuzumab
Indication
Disease Entry ICD 11 Status REF
Breast cancer 2C60-2C65 Phase 2 [1]
Colorectal cancer 2B91.Z Phase 2 [1]
Liver cancer 2C12 Phase 2 [1]
Ovarian cancer 2C73 Phase 2 [1]
Pancreatic cancer 2C10 Phase 2 [1]
Drug Type
Monoclonal antibody
Cross-matching ID
UNII
237GB6IDKO
DrugBank ID
DB15101
TTD ID
D03LTO
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 ClinicalTrials.gov (NCT01307891) Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer. U.S. National Institutes of Health.